A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India

Tuberculosis (TB) and mental illnesses frequently coexist and are both extremely common worldwide. Through the National Program for Elimination of Tuberculosis (NTEP), anti-tuberculosis therapy (ATT) medications are used to treat tuberculosis in India. We want to report a case 45-year-old patient fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathiyamoorthi, Sathiyanarayanan, Pentapati, Siva Santosh Kumar, Vullanki, Sai Sreeja, Avula, Vijaya Chandra Reddy, Aravindakshan, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147993/
https://www.ncbi.nlm.nih.gov/pubmed/37128519
http://dx.doi.org/10.7759/cureus.36893
_version_ 1785034903803396096
author Sathiyamoorthi, Sathiyanarayanan
Pentapati, Siva Santosh Kumar
Vullanki, Sai Sreeja
Avula, Vijaya Chandra Reddy
Aravindakshan, Rajeev
author_facet Sathiyamoorthi, Sathiyanarayanan
Pentapati, Siva Santosh Kumar
Vullanki, Sai Sreeja
Avula, Vijaya Chandra Reddy
Aravindakshan, Rajeev
author_sort Sathiyamoorthi, Sathiyanarayanan
collection PubMed
description Tuberculosis (TB) and mental illnesses frequently coexist and are both extremely common worldwide. Through the National Program for Elimination of Tuberculosis (NTEP), anti-tuberculosis therapy (ATT) medications are used to treat tuberculosis in India. We want to report a case 45-year-old patient from the state of Andhra Pradesh, India with comorbid delusional disorder leading to daily ATT drug consumption for the past 20 years. This unusual presentation demonstrates that abuse of a Schedule "H" substance like ATT is also conceivable. To stop "Off-label" purchases, strict measures must be taken. Before beginning ATT, evaluating the patient's mental health may be a wise move.
format Online
Article
Text
id pubmed-10147993
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101479932023-04-30 A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India Sathiyamoorthi, Sathiyanarayanan Pentapati, Siva Santosh Kumar Vullanki, Sai Sreeja Avula, Vijaya Chandra Reddy Aravindakshan, Rajeev Cureus Psychiatry Tuberculosis (TB) and mental illnesses frequently coexist and are both extremely common worldwide. Through the National Program for Elimination of Tuberculosis (NTEP), anti-tuberculosis therapy (ATT) medications are used to treat tuberculosis in India. We want to report a case 45-year-old patient from the state of Andhra Pradesh, India with comorbid delusional disorder leading to daily ATT drug consumption for the past 20 years. This unusual presentation demonstrates that abuse of a Schedule "H" substance like ATT is also conceivable. To stop "Off-label" purchases, strict measures must be taken. Before beginning ATT, evaluating the patient's mental health may be a wise move. Cureus 2023-03-29 /pmc/articles/PMC10147993/ /pubmed/37128519 http://dx.doi.org/10.7759/cureus.36893 Text en Copyright © 2023, Sathiyamoorthi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychiatry
Sathiyamoorthi, Sathiyanarayanan
Pentapati, Siva Santosh Kumar
Vullanki, Sai Sreeja
Avula, Vijaya Chandra Reddy
Aravindakshan, Rajeev
A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
title A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
title_full A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
title_fullStr A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
title_full_unstemmed A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
title_short A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
title_sort case of delusional disorder with abuse of isoniazid, rifampicin, pyrazinamide, and ethambutol, the first-line anti-tuberculosis therapy drugs in india
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147993/
https://www.ncbi.nlm.nih.gov/pubmed/37128519
http://dx.doi.org/10.7759/cureus.36893
work_keys_str_mv AT sathiyamoorthisathiyanarayanan acaseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT pentapatisivasantoshkumar acaseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT vullankisaisreeja acaseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT avulavijayachandrareddy acaseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT aravindakshanrajeev acaseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT sathiyamoorthisathiyanarayanan caseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT pentapatisivasantoshkumar caseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT vullankisaisreeja caseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT avulavijayachandrareddy caseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia
AT aravindakshanrajeev caseofdelusionaldisorderwithabuseofisoniazidrifampicinpyrazinamideandethambutolthefirstlineantituberculosistherapydrugsinindia

Ejemplares similares